Literature DB >> 14647496

Homeostatic proliferation is a barrier to transplantation tolerance.

Zihao Wu1, Steven J Bensinger, Jidong Zhang, Chuangqi Chen, Xueli Yuan, Xiaolun Huang, James F Markmann, Alireza Kassaee, Bruce R Rosengard, Wayne W Hancock, Mohamed H Sayegh, Laurence A Turka.   

Abstract

Despite the ease of inhibiting immune responses by blockade of T-cell costimulation in naive rodent models, it is difficult to suppress those responses in animals with memory cells. Studies demonstrating the importance of alloreactive T-cell deletion during tolerance induction have promoted use of peritransplant T-cell-depleting therapies in clinical trials. But potentially complicating wide-scale, nonspecific T-cell depletion is the finding that extensive T-cell proliferation can occur under conditions of lymphopenia. This process, termed homeostatic proliferation, may induce acquisition of functional memory T cells. Here, using clinically relevant mouse models of peripheral T-cell depletion, we show that residual nondepleted T cells undergo substantial homeostatic expansion. In this setting, costimulatory blockade neither significantly suppresses homeostatic proliferation nor prevents allograft rejection. In addition, T cells that have completed homeostatic proliferation show dominant resistance to tolerance when adoptively transferred into wild-type recipients, consistent with known properties of memory cells in vivo. These findings establish the importance of homeostatic proliferation in clinically relevant settings, demonstrate the barrier that homeostatic proliferation can present to the induction of transplantation tolerance, and have important implications for transplantation protocols that use partial or complete peripheral T-cell depletion.

Entities:  

Mesh:

Year:  2003        PMID: 14647496      PMCID: PMC2839903          DOI: 10.1038/nm965

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  28 in total

1.  Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance.

Authors:  Y Li; X C Li; X X Zheng; A D Wells; L A Turka; T B Strom
Journal:  Nat Med       Date:  1999-11       Impact factor: 53.440

2.  Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance.

Authors:  A D Wells; X C Li; Y Li; M C Walsh; X X Zheng; Z Wu; G Nuñez; A Tang; M Sayegh; W W Hancock; T B Strom; L A Turka
Journal:  Nat Med       Date:  1999-11       Impact factor: 53.440

3.  Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question.

Authors:  E J Suchin; P B Langmuir; E Palmer; M H Sayegh; A D Wells; L A Turka
Journal:  J Immunol       Date:  2001-01-15       Impact factor: 5.422

4.  Cutting edge: naive T cells masquerading as memory cells.

Authors:  K Murali-Krishna; R Ahmed
Journal:  J Immunol       Date:  2000-08-15       Impact factor: 5.422

5.  Homeostasis and anergy of CD4(+)CD25(+) suppressor T cells in vivo.

Authors:  Marc A Gavin; Sally R Clarke; Ella Negrou; Alena Gallegos; Alexander Rudensky
Journal:  Nat Immunol       Date:  2001-12-10       Impact factor: 25.606

6.  Homeostatic expansion occurs independently of costimulatory signals.

Authors:  M Prlic; B R Blazar; A Khoruts; T Zell; S C Jameson
Journal:  J Immunol       Date:  2001-11-15       Impact factor: 5.422

7.  A closer look at homeostatic proliferation of CD4+ T cells: costimulatory requirements and role in memory formation.

Authors:  H Gudmundsdottir; L A Turka
Journal:  J Immunol       Date:  2001-10-01       Impact factor: 5.422

Review 8.  Mixed chimerism and transplant tolerance.

Authors:  M Sykes
Journal:  Immunity       Date:  2001-04       Impact factor: 31.745

9.  Homeostatic expansion and phenotypic conversion of naïve T cells in response to self peptide/MHC ligands.

Authors:  W C Kieper; S C Jameson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

10.  Naive T cells transiently acquire a memory-like phenotype during homeostasis-driven proliferation.

Authors:  A W Goldrath; L Y Bogatzki; M J Bevan
Journal:  J Exp Med       Date:  2000-08-21       Impact factor: 14.307

View more
  150 in total

Review 1.  Exploitation of the propulsive force of chemotherapy for improving the response to cancer immunotherapy.

Authors:  Enrico Proietti; Federica Moschella; Imerio Capone; Filippo Belardelli
Journal:  Mol Oncol       Date:  2011-12-03       Impact factor: 6.603

Review 2.  CD4(+)Foxp3(+) regulatory T cell therapy in transplantation.

Authors:  Qizhi Tang; Jeffrey A Bluestone; Sang-Mo Kang
Journal:  J Mol Cell Biol       Date:  2011-12-14       Impact factor: 6.216

3.  Arthritogenic self-reactive CD4+ T cells acquire an FR4hiCD73hi anergic state in the presence of Foxp3+ regulatory T cells.

Authors:  Ryan J Martinez; Na Zhang; Stephanie R Thomas; Sarada L Nandiwada; Marc K Jenkins; Bryce A Binstadt; Daniel L Mueller
Journal:  J Immunol       Date:  2011-11-28       Impact factor: 5.422

Review 4.  Mixed chimerism and split tolerance: mechanisms and clinical correlations.

Authors:  David P Al-Adra; Colin C Anderson
Journal:  Chimerism       Date:  2011 Oct-Dec

5.  Homeostatic expansion and phenotypic conversion of human T cells depend on peripheral interactions with APCs.

Authors:  Takashi Onoe; Hannes Kalscheuer; Meredith Chittenden; Guiling Zhao; Yong-Guang Yang; Megan Sykes
Journal:  J Immunol       Date:  2010-05-10       Impact factor: 5.422

6.  Contributions of direct and indirect alloresponses to chronic rejection of kidney allografts in nonhuman primates.

Authors:  Ognjenka Nadazdin; Svjetlan Boskovic; Siew-Lin Wee; Hiroshi Sogawa; Ichiro Koyama; Robert B Colvin; R Neal Smith; Georges Tocco; David H O'Connor; Julie A Karl; Joren C Madsen; David H Sachs; Tatsuo Kawai; A Benedict Cosimi; Gilles Benichou
Journal:  J Immunol       Date:  2011-09-28       Impact factor: 5.422

Review 7.  Immunologic basis of graft rejection and tolerance following transplantation of liver or other solid organs.

Authors:  Alberto Sánchez-Fueyo; Terry B Strom
Journal:  Gastroenterology       Date:  2010-11-09       Impact factor: 22.682

Review 8.  Immuno-intervention for the induction of transplantation tolerance through mixed chimerism.

Authors:  David H Sachs; Megan Sykes; Tatsuo Kawai; A Benedict Cosimi
Journal:  Semin Immunol       Date:  2011-08-11       Impact factor: 11.130

9.  Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: with particular reference to hepatitis C virus.

Authors:  Amadeo Marcos; Bijan Eghtesad; John J Fung; Paulo Fontes; Kusum Patel; Michael Devera; Wallis Marsh; Timothy Gayowski; Anthony J Demetris; Edward A Gray; Bridget Flynn; Adriana Zeevi; Noriko Murase; Thomas E Starzl
Journal:  Transplantation       Date:  2004-10-15       Impact factor: 4.939

10.  CD4(+) CD44(v.low) cells are unique peripheral precursors that are distinct from recent thymic emigrants and stem cell-like memory cells.

Authors:  Chunfang Zhao; Idania Marrero; Aditi Narsale; Rosita Moya; Joanna D Davies
Journal:  Cell Immunol       Date:  2015-04-17       Impact factor: 4.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.